Illicit drug use and neonatal outcomes: A critical review

Obstetrical and Gynecological Survey

Volumn 62, Issue 11, 2007, Pages 749-757

  Schempf, Ashley H ^a  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CANNABIS; COCAINE; ILLICIT DRUG; OPIATE;

ALCOHOL CONSUMPTION; CLINICAL TRIAL; DRUG ABUSE; DRUG BLOOD LEVEL; FETUS GROWTH; FETUS WEIGHT; GESTATIONAL AGE; HEAD CIRCUMFERENCE; HUMAN; INTRAUTERINE GROWTH RETARDATION; LIPID STORAGE; META ANALYSIS; NEWBORN CARE; PERINATAL DEVELOPMENT; PREGNANCY OUTCOME; PRENATAL DRUG EXPOSURE; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE; ADDICTION; ADOLESCENT; ADULT; DRUG EFFECT; FEMALE; LOW BIRTH WEIGHT; NEWBORN; PATHOPHYSIOLOGY; PLACENTA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL EXPOSURE; WITHDRAWAL SYNDROME;

ADOLESCENT; ADULT; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; NEONATAL ABSTINENCE SYNDROME; PLACENTA; PREGNANCY; PREGNANCY COMPLICATIONS; PREGNANCY OUTCOME; PRENATAL EXPOSURE DELAYED EFFECTS; SUBSTANCE-RELATED DISORDERS;

EID: 38449108713     PISSN: 00297828     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ogx.0000286562.31774.76     Document Type: Review

References (88)

1. Substance Abuse and Mental Health Services Administration. Substance use during pregnancy: 2002-2003 update. NSDUH Report. Rockville MD: SAMHSA, June 2, 2005.
2. Bendersky M, Alessandri S, Gilbert P, et al. Characteristics of pregnant substance abusers in two cities in the northeast. Am J Drug Alcohol Abuse 1996;22:349-362.
3. Frank DA, Zuckerman BS, Amaro H, et al. Cocaine use during pregnancy: prevalence and correlates. Pediatrics 1988;82:888-895.
4. Gillogley KM, Evans AT, Hansen RL, et al. The perinatal impact of cocaine, amphetamine, and opiate use detected by universal intrapartum screening. Am J Obstet Gynecol 1990;163:1535-1542.
5. Feldman JG, Minkoff HL, McCalla S, et al. A cohort study of the impact of perinatal drug use on prematurity in an inner-city population. Am J Public Health 1992;82:726-728.
6. Streissguth AP, Grant TM, Barr HM, et al. Cocaine and the use of alcohol and other drugs during pregnancy. Am J Obstet Gynecol 1991;164:1239-1243.
7. Chiriboga CA. Fetal alcohol and drug effects. Neurologist 2003;9:267-279.
8. Bauer CR. Perinatal effects of prenatal drug exposure. Neonatal aspects. Clin Perinatol 1999;26:87-106.
9. Bauer CR, Shankaran S, Bada HS, et al. The Maternal Lifestyle Study: drug exposure during pregnancy and short-term maternal outcomes. Am J Obstet Gynecol 2002;186:487-495.
10. Curry MA. The interrelationships between abuse, substance use, and psychosocial stress during pregnancy. J Obstet Gynecol Neonatal Nurs 1998;27:692-629.
11. Robins L, Mills J. Effects of in utero exposure to street drugs. Am J Public Health 1993;83 (Suppl):1-32.
12. Christmas JT, Knisely JS, Dawson KS, et al. Comparison of questionnaire screening and urine toxicology for detection of pregnancy complicated by substance use. Obstet Gynecol 1992;80:750-754.
13. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med 1989;320:762-768.
14. Frank DA, Augustyn M, Zuckerman BS. Neonatal neurobehavioral and neuroanatomic correlates of prenatal cocaine exposure. Problems of dose and confounding. Ann N Y Acad Sci 1998;846:40-50.
15. Kuhn L, Kline J, Ng S, et al. Cocaine use during pregnancy and intrauterine growth retardation: new insights based on maternal hair tests. Am J Epidemiol 2000;152:112-119.
16. Breslau N, Paneth NS, Lucia VC. The lingering academic deficits of low birth weight children. Pediatrics 2004;114:1035-1040.
17. Arias E, MacDorman MF, Strobino DM, et al. Annual summary of vital statistics - 2002. Pediatrics 2003;112:1215-1230.
18. McCormick MC. The contribution of low birth weight to infant mortality and childhood morbidity. N Engl J Med 1985;312:82-90.
19. Kirkegaard I, Obel C, Hedegaard M, et al. Gestational age and birth weight in relation to school performance of 10-year-old children: a follow-up study of children born after 32 completed weeks. Pediatrics 2006;118:1600-1606.
20. Barker DJ, Eriksson JG, Forsen T, et al. Fetal origins of adult disease: strength of effects and biological basis. Int J Epidemiol 2002;31:1235-1239.
21. Zuckerman B, Frank D, Brown E. Overview of the effects of abuse and drugs on pregnancy and offspring. NIDA Res Monogr 1995;149:16-38.
22. Shiono PH, Klebanoff MA, Nugent RP, et al. The impact of cocaine and marijuana use on low birth weight and preterm birth: a multicenter study. Am J Obstet Gynecol 1995;172:19-27.
23. Jacobson JL, Jacobson SW, Sokol RJ, et al. Effects of alcohol use, smoking, and illicit drug use on fetal growth in black infants. J Pediatr 1994;124:7577-64.
24. Kliegman RM, Madura D, Kiwi R, et al. Relation of maternal cocaine use to the risks of prematurity and low birth weight. J Pediatr 1994;124:751-756.
25. Smith LM, LaGasse LL, Derauf C, et al. The infant development, environment, and lifestyle study: effects of prenatal methamphetamine exposure, polydrug exposure, and poverty on intrauterine growth. Pediatrics 2006;118:1149-1156.
26. Shankaran S, Das A, Bauer CR, et al. Association between patterns of maternal substance use and infant birth weight, length, and head circumference. Pediatrics 2004;114:e226-e34.
27. Day N, Sambamoorthi U, Taylor P, et al. Prenatal marijuana use and neonatal outcome. Neurotoxicol Teratol 1991;13:329-334.
28. Eyler FD, Behnke M, Conlon M, et al. Birth outcome from a prospective, matched study of prenatal crack/cocaine use. I. Interactive and dose effects on health and growth. Pediatrics 1998;101:229-237.
29. Singer LT, Salvator A, Arendt R, et al. Effects of cocaine/polydrug exposure and maternal psychological distress on infant birth outcomes. Neurotoxicol Teratol 2002;24:127-135.
30. Richardson GA, Hamel SC, Goldschmidt L, et al. Growth of infants prenatally exposed to cocaine/crack: comparison of a prenatal care and a no prenatal care sample. Pediatrics 1999;104:e18.
31. Bandstra ES, Morrow CE, Anthony JC, et al. Intrauterine growth of full-term infants: impact of prenatal cocaine exposure. Pediatrics 2001;108:1309-1319.
32. Fergusson DM, Horwood LJ, Northstone K. Maternal use of cannabis and pregnancy outcome. BJOG 2002;109:21-27.
33. Fried PA, O'Connell CM. A comparison of the effects of prenatal exposure to tobacco, alcohol, cannabis and caffeine on birth size and subsequent growth. Neurotoxicol Teratol 1987;9:79-85.
34. Visscher WA, Feder M, Burns AM, et al. The impact of smoking and other substance use by urban women on the birthweight of their infants. Subst Use Misuse 2003;38:1063-1093.
35. Bada HS, Das A, Bauer CR, et al. Low birth weight and preterm births: etiologic fraction attributable to prenatal drug exposure. J Perinatol 2005;25:631-637.
36. Bada HS, Das A, Bauer CR, et al. Gestational cocaine exposure and intrauterine growth: maternal lifestyle study. Obstet Gynecol 2002;100:916-924.
37. English DR, Hulse GK, Milne E, et al. Maternal cannabis use and birth weight: a meta-analysis. Addiction 1997;92:1553-1560.
38. Hulse GK, Milne E, English DR, et al. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997;92:1571-1579.
39. Lifschitz MH, Wilson GS, Smith EO, et al. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985;75:269-274.
40. Lifschitz MH, Wilson GS, Smith EO, et al. Fetal and postnatal growth of children born to narcotic-dependent women. J Pediatr 1983;102:686-691.
41. Woods JR Jr, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA 1987;257:957-961.
42. Fajemirokun-Odudeyi O, Lindow SW. Obstetric implications of cocaine use in pregnancy: a literature review. Eur J Obstet Gynecol Reprod Biol 2004;112:2-8.
43. Richardson GA, Day NL, McGauhey PJ. The impact of prenatal marijuana and cocaine use on the infant and child. Clin Obstet Gynecol 1993;36:302-318.
44. Sprauve ME, Lindsay MK, Herbert S, et al. Adverse perinatal outcome in parturients who use crack cocaine. Obstet Gynecol 1997;89:674-678.
45. Handler A, Kistin N, Davis F, et al. Cocaine use during pregnancy: perinatal outcomes. Am J Epidemiol 1991;133:818-825.
46. Bateman DA, Chiriboga CA. Dose-response effect of cocaine on newborn head circumference. Pediatrics 2000;106:E33.
47. Bateman DA, Ng SK, Hansen CA, et al. The effects of intrauterine cocaine exposure in newborns. Am J Public Health 1993;83:190-193.
48. Chiriboga CA, Brust JC, Bateman D, et al. Dose-response effect of fetal cocaine exposure on newborn neurologic function. Pediatrics 1999;103:79-85.
49. Mirochnick M, Frank DA, Cabral H, et al. Relation between meconium concentration of the cocaine metabolite benzoylecgonine and fetal growth. J Pediatr 1995;126:636-638.
50. Richardson GA, Day NL. Maternal and neonatal effects of moderate cocaine use during pregnancy. Neurotoxicol Teratol 1991;13:455-460.
51. Miller JM Jr, Boudreaux MC. A study of antenatal cocaine use-chaos in action. Am J Obstet Gynecol 1999;180:1427-1431.
52. Neuspiel DR, Markowitz M, Drucker E. Intrauterine cocaine, lead, and nicotine exposure and fetal growth. Am J Public Health 1994;84:1492-1495.
53. Savitz DA, Henderson L, Dole N, et al. Indicators of cocaine exposure and preterm birth. Obstet Gynecol 2002;99:458-465.
54. Addis A, Moretti ME, Ahmed Syed F, et al. Fetal effects of cocaine: an updated meta-analysis. Reprod Toxicol 2001;15:341-369.
55. Eyler FD, Behnke M, Conlon M, et al. Birth outcome from a prospective, matched study of prenatal crack/cocaine use. II. Interactive and dose effects on neurobehavioral assessment. Pediatrics 1998;101:237-241.
56. Delaney-Black V, Covington C, Ostrea E Jr, et al. Prenatal cocaine and neonatal outcome: evaluation of dose-response relationship. Pediatrics 1996;98:735-740.
57. Lester BM, Tronick EZ, LaGasse L, et al. The Maternal Lifestyle Study: effects of substance exposure during pregnancy on neurodevelopmental outcome in 1-month-old infants. Pediatrics 2002;110:1182-1192.
58. Bauer CR, Langer JC, Shankaran S, et al. Acute neonatal effects of cocaine exposure during pregnancy. Arch Pediatr Adolesc Med 2005;159:824-834.
59. Hulse GK, Milne E, English DR, et al. Assessing the relationship between maternal cocaine use and abruptio placentae. Addiction 1997;92:1547-1551.
60. Lumley J, Oliver SS, Chamberlain C, et al. Interventions for promoting smoking cessation during pregnancy. Cochrane Database Syst Rev 2004:CD001055.
61. Elk R, Mangus L, Rhoades H, et al. Cessation of cocaine use during pregnancy: effects of contingency management interventions on maintaining abstinence and complying with prenatal care. Addict Behav 1998;23:57-64.
62. Carroll KM, Chang G, Behr H, et al. Improving treatment outcome in pregnant, methadone-maintained women: results from a randomized clinical trial. Am J Addict 1995;4:56-59.
63. Frank DA, Augustyn M, Knight WG, et al. Growth, development, and behavior in early childhood following prenatal cocaine exposure: a systematic review. JAMA 2001;285:1613-1625.
64. Messinger DS, Bauer CR, Das A, et al. The maternal lifestyle study: cognitive, motor, and behavioral outcomes of cocaine-exposed and opiate-exposed infants through three years of age. Pediatrics 2004;113:1677-1685.
65. Singer LT, Minnes S, Short E, et al. Cognitive outcomes of preschool children with prenatal cocaine exposure. JAMA 2004;291:2448-2456.
66. Lester BM, LaGasse LL, Seifer R. Cocaine exposure and children: the meaning of subtle effects. Science 1998;282:633-634.
67. Slotkin TA. Fetal nicotine or cocaine exposure: which one is worse? J Pharmacol Exp Ther 1998;285:931-945.
68. Weitzman M, Byrd RS, Aligne CA, et al. The effects of tobacco exposure on children's behavioral and cognitive functioning: implications for clinical and public health policy and future research. Neurotoxicol Teratol 2002;24:397-406.
69. Hans SL. Demographic and psychosocial characteristics of substance-abusing pregnant women. Clin Perinatol 1999;26:55-74.
70. Wolfe EL, Davis T, Guydish J, et al. Mortality risk associated with perinatal drug and alcohol use in California. J Perinatol 2005;25:93-100.
71. Phibbs CS, Bateman DA, Schwartz RM. The neonatal costs of maternal cocaine use. JAMA 1991;266:1521-1526.
72. Behnke M, Eyler FD, Conlon M, et al. How fetal cocaine exposure increases neonatal hospital costs. Pediatrics 1997;99:204-208.
73. Thadani PV, Strauss JF 3rd, Dey SK, et al. National Institute on Drug Abuse Conference report on placental proteins, drug transport, and fetal development. Am J Obstet Gynecol 2004;191:1858-1862.
74. Paarlberg KM, Vingerhoets AJ, Passchier J, et al. Psychosocial factors and pregnancy outcome: a review with emphasis on methodological issues. J Psychosom Res 1995;39:563-595.
75. Wadhwa PD, Culhane JF, Rauh V, et al. Stress and preterm birth: neuroendocrine, immune/inflammatory, and vascular mechanisms. Matern Child Health J 2001;5:119-125.
76. Wadhwa PD, Dunkel-Schetter C, Chicz-DeMet A, et al. Prenatal psychosocial factors and the neuroendocrine axis in human pregnancy. Psychosom Med 1996;58:432-446.
77. Lindenberg CS, Reiskin HK, Gendrop SC. The social stress model of substance abuse among childbearing-age women: a review of the literature. J Drug Educ 1994;24:253-268.
78. Finch BK, Vega WA, Kolody B. Substance use during pregnancy in the state of California, USA. Soc Sci Med 2001;52:571-583.
79. Petronis KR, Anthony JC. A different kind of contextual effect: geographical clustering of cocaine incidence in the USA. J Epidemiol Community Health 2003;57:893-900.
80. Pearl M, Braveman P, Abrams B. The relationship of neighborhood socioeconomic characteristics to birthweight among 5 ethnic groups in California. Am J Public Health 2001;91:1808-1814.
81. Morenoff JD. Neighborhood mechanisms and the spatial dynamic of birth weight. Am J Sociol 2003;108:976-1017.
82. Kaufman JS, Dole N, Savitz DA, et al. Modeling community-level effects on preterm birth. Ann Epidemiol 2003;13:377-384.
83. Ponce NA, Hoggatt KJ, Wilhelm M, et al. Preterm birth: the interaction of traffic-related air pollution with economic hardship in Los Angeles neighborhoods. Am J Epidemiol 2005;162:140-148.
84. Salam MT, Millstein J, Li YF, et al. Birth outcomes and prenatal exposure to ozone, carbon monoxide, and particulate matter: results from the Children's Health Study. Environ Health Perspect 2005;113:1638-1644.
85. Rauh VA, Whyatt RM, Garfinkel R, et al. Developmental effects of exposure to environmental tobacco smoke and material hardship among inner-city children. Neurotoxicol Teratol 2004;26:373-385.
86. Snijders TAB, Bosker RJ. Multilevel Analysis: An Introduction to Basic and Advanced Multilevel Modeling. Thousand Oaks, CA: Sage Publications, 1999.
87. Diez-Roux AV. Multilevel analysis in public health research. Annu Rev Public Health 2000;21:171-192.
88. D'Agostino RB Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 1998;17:2265-2281.